Kyto Technology And Life Science Inc (KBPH) Return on Equity ROE from the third quarter 2022 to third quarter 2021 and annually, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Kyto Technology And Life Science Inc   (KBPH)

Kyto Technology And Life Science Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Kyto Technology And Life Science Inc in the third quarter 2022?
Kyto Technology And Life Science Inc achieved a return on average equity (ROE) of 11.56 % in its third quarter 2022 a new company high.

While the company's net income was fading, Kyto Technology And Life Science Inc was able to improve its ROE compared to the second quarter 2022.

Within the Major Pharmaceutical Preparations industry 63 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2022 from 1787 to 1862.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2021)
III. Quarter		 (Sep 30 2021)
II. Quarter		 (Jun 30 2021)
I. Quarter		 (Mar 31 2021)
IV. Quarter		 (Dec 31 2020)
III. Quarter
Y / Y Equity Change 101.76 % 155.7 % 184.12 % 162.15 % -
Y / Y Net Income Change - 213.11 % - - -
Net Income (TTM) in Millions 1 1 0 0 0
Return On Equity (TTM) 11.56 % 9.9 % 2.02 % 8.28 % -2.11 %
KBPH's Total Ranking # 1862 # 1787 # 2512 # 1740 # 2719
Equity (TTM) in Millions 13 11 9 7 6
Seq. Equity Change 19.35 % 26.71 % 22.08 % 9.28 % 51.26 %
Seq. Net Income Change -67.86 % - - - -

Back to KBPH Management Effectiveness >> KBPH's 5 Years Annual ROE >> Compare KBPH ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 64
Sector # 164
Overall # 1862

Return On Equity Statistics
High Average Low
11.56 %
-10.56 %
-30.15 %
(Dec 31 2021)   (Mar 31 2020)





KBPH Annual Return On Equity (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019

Total Equity in Millions 7 3 2 0 0
Y / Y Equity Change 162.15 % 70.59 % - - -
Net Income in Millions 0 -1 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 6.11 % -28.99 % -14.72 % - -

Back to KBPH Management Effectiveness >> KBPH's 5 Years Annual ROE >> Compare KBPH ROE to its Competitors




Annual Roe Comment
In 2021 ROE improved to 6.11 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
KBPH's' Return on Equity at Yahoo Finance
KBPH's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for KBPH's Competitors
Subscribers only: Roe for Kyto Technology And Life Science Inc 's Suppliers
Subscribers only: Return On Equity for KBPH's Customers




Companies with similar Return On Equity at Dec 31 2021, within Healthcare Sector ROE
West Pharmaceutical Services Inc   31.52 %
Gilead Sciences Inc   30.54 %
Progyny Inc   30.41 %
Incyte Corporation  30.16 %
Pfizer Inc  30.11 %
Johnson and Johnson  29.86 %
Edwards Lifesciences Corporation  28.40 %
Purple Biotech Ltd  28.37 %
Lifevantage Corp  27.37 %
Zynex inc   27.28 %
Sunlink Health Systems Inc   26.93 %
Bruker Corporation  26.91 %
Exelixis Inc   25.38 %
Vertex Pharmaceuticals Inc  24.78 %
Avid Bioservices Inc   24.46 %
Harmony Biosciences Holdings inc   24.15 %
Agilent Technologies inc   23.47 %
Amedisys Inc  23.41 %
Encompass Health Corporation  23.41 %
Lftd Partners Inc   23.32 %
Pro dex Inc   23.31 %
Labcorp Holdings Inc   23.18 %
Corcept Therapeutics Inc  23.09 %
Phibro Animal Health Corporation  23.01 %
Koninklijke Philips Nv  22.96 %
Regenxbio Inc   22.35 %
Sotera Health Company  22.30 %
Align Technology inc   22.19 %
Ensign Group Inc  20.78 %
Escalon Medical Corp   20.77 %

Date modified: 2022-03-01T22:51:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.